Shelter Pharma Ltd (SHELTER) quarterly results

AI summary: Earnings call, Q4 FY26

Earnings call of 19 Jun 2026, summarised by AI from the filing.

Shelter Pharma FY26 revenue ₹73.13 cr, up 44%, with FY30 target of around ₹200.00 cr and EBITDA margin at 17.39%.

Key takeaways

1. FY30 target Targeting annual revenues of around ₹200.00 cr till FY2030 through capacity expansion, innovation-driven product launches, and global market penetration.
2. Export driver Exports grew 164% to ₹6 cr in FY26, with Africa and government procurement schemes targeted for volume growth.

Shelter Pharma Ltd earnings call summary

Original filing on BSE

Shelter Pharma Ltd earnings call, investor presentation and press release summaries

• Q4 FY26: Earnings call (19 Jun 2026), Results deck (17 Jun 2026)